ALIMS Approves The Sale Of 295 New Medicines

News: The Medicines and Medical Devices Agency of Serbia (ALIMS) has granted approval to the sale of 295 new medicines in Serbia, reports Of these 295 newly approved medicines, nine medicines are for the treatment of rare diseases. ALIMS granted approval to the sale of these medicines in 2013, according to ALIMS spokesperson Alexander Tucovic. The agency had also discussed the issue of registering 313 new medicines in the country, of which the registration of 39 medicines has been approved, Tucovic added.

This article is tagged to:
Related sectors of this article: Pharmaceuticals & Healthcare, Regulatory - Pharmaceuticals & Healthcare
Geography: Serbia

Enter your details to read the full article

By submitting this form you are acknowledging that you have read and understood our Privacy Policy.